Sruti Ramachandran Nair

Love this article :10 high-value use cases for predictive analytics in healthcare For those who need case studies to believe in the convergence of precision medicine, data analytics to power value based care ... this article is for you.. https://lnkd.in/eKkCUVFm Precision medicine is the GenAI of Value Based care .

23

Another day, another reason why you should join us at IQVIA, seriously what are you waiting for??? As a #ClinicalResearchAssociate you will have access to top-tier training resources, encompassing everything from virtual learning modules to hands-on activities and comprehensive mentorship programs. These tools will not only enhance your professional skills but also empower you to make significant contributions to the field of clinical research. Curious about the limitless possibilities of our #CRA Training Program? Find out more here: https://bit.ly/3RzHUWf #IQVIA #ClinicalResearch #ProfessionalDevelopment"

9

Exciting news in the clinical trial space! 🚀 Labcorp has just launched Global Trial Connect, a suite of digital and data solutions designed to accelerate clinical trials. Key features include: ✅ Site enablement resources ✅ Supply readiness support ✅ Site workflow facilitation ✅ Study management and investigator support This development could significantly impact the speed at which new therapies reach patients. What are your thoughts on how technology is transforming clinical trials? #ClinicalTrials #HealthcareInnovation #Labcorp #MedicalResearch

4

Life sciences organizations all generate significant #data that can and should be leveraged to empower better patient outcomes, further exploratory research, and more agile science. Explore the value of R&D data #accessibility here: https://lnkd.in/eCfJtkbU

2

Have you heard about Veeva's new Email Builder for Approved Emails? It's a great tool for quickly building basic emails with approved text, and is a fantastic addition to the various Approved Email options available from Veeva. If you're looking to really optimise your customer engagement through Veeva, you need to take it a step further: have you thought about sending emails that mirror the conversations that account managers are having with their customers? With our Approved Emails, your field teams can send emails to their customers that reflect the data and budget impact scenarios that they used in their conversations. Allowing you to develop conversation-specific and compliant reports. In this short demo, my colleague, Lydia Crowe (Director – Commercial), shows us how this works: https://lnkd.in/e42-v4wT To find out more, email info@mtechaccess.co.uk #approvedemail #Veevapartners #marketaccess #customerengagement #budgetimpactmodel #Pharma #MedicalDevices

3

Food for thought: • Any quality requires data to be measured • Bad data prevents you from understanding the quality of anything • It gets worse if you use bad data to measure data – you might never find out that your data is bad. • You better ensure good data quality by design I'd be happy to read your comments. My bi-weekly "Food for Thought" series invites you to share your ideas. #data #cdo #datamanagement #foodforthought

31

2 Comments

Project story: Shortest conversation with my manager Manager: Vivek, your name popped up during a conversation for staffing on a new project. Do you want to know who recommended your name? I (Who is already neck deep in projects): Sure. So that I know whom to blame? Manager: That was me! (Silence)! 😨

12

Partnerships start with collaboration and an understanding of client culture. It is important to understand if a potential vendor shares the same values through a comprehensive RFP that also measures problem solving and personality traits. It is not about what you have....It is how you are going to customize an approach that best serves the client.

9

I posted about dirty data and what it looks like a couple of weeks ago. If you've missed it, check it out here: https://lnkd.in/g2mU2BR7 Now, let's talk about ideal data and what that looks like. There are ten traits, but we’ll focus on five today: High Volume, Historical, Consistent, Multivariate, and Atomic. 🔘High Volume: Imagine having a huge library of books. You might not read every book, but having a large collection increases the chances of finding the information you need. Similarly, having a lot of data means you're more likely to find the answers you're looking for, even though we may not use all of it. 🔘Historical: Think of looking through old photo albums. You can understand the present better by seeing how things have changed over the years. Historical data works the same way; it helps us see patterns and trends over time. 🔘Consistent: Picture trying to compare the scores of two different sports teams, but one team keeps changing its players' names and positions. It would be confusing, right? A good example of this in a business setting is the ever-changing boundaries that define sales territories. Consistent data means that the information stays the same or is adjusted in a clear way, making comparisons easier. 🔘Multivariate: Imagine you're trying to figure out why your garden is flourishing this year. You might look at several factors: the amount of sunlight, the type of soil, the amount of water, and the types of plants. In data terms, these are different variables. The more variables you have, the better you can understand the whole picture. 🔘Atomic (Granular): Think of a jigsaw puzzle. Sometimes you need to look closely at individual pieces to understand where they fit. Atomic data is like having each tiny piece of information available so you can zoom in and see the smallest details when needed. What do you think the remaining five traits might be? 📻 Stay tuned to find out! #DataQuality #DataAnalytics #DataScience #Analytics #DataDriven

13

4 Comments

Have you ever had 2 versions of a spreadsheet you need to compare but want a bit of help with automating the task? 🤔🤓📊 Microsoft has a tool called Spreadsheet Compare under its Microsoft Office Tools collection. If you upload both spreadsheets you can pick and choose what you wish to compare such as value cells, formula cells and calculated cells and it not only lists the changes by type, cell and sheet but as you select a change both spreadsheets navigate to the referenced cell. You can export the list of changes too. In the below example I have created 2 dummy datasets. The first with 4 months of values and the remainder months with a forecast.ets(). The second set wraps an if() around the forecast.ets() to check for negative forecasts, zeroises and highlights them. Then manual inputs override some of the zeros. I can see how many cells changed, what the changes were and also the overall impact in the chart. I have a Personal Office 365 subscription with Power BI Desktop license added in and the Spreadsheet Compare tool is included. Working with data and creative solutions is not only my job but my hobby too 😉 More details are here: https://lnkd.in/eRVazsT4 #HappyLittleGeek #Excel #ExcelTips #SpreadsheetCompare #Forecasting

10

3 Comments

Interesting article by ZS outlining pharma’s commercial model of the future, focusing on driving behavior-changing, personalized customer experience at scale by defining CONTEXT and its value in differentiated data strategy. I particularly appreciate the insights visualized in figures 3-5 within: FIGURE 3: The context wheel helps us see customers more fully FIGURE 4: Building blocks for the CONTEXT stream FIGURE 5: Aligning your capabilities to your existing data ecosystem

5

2 Comments

NBRx story: Is #Patients or #NBRx or #NRx better metric for Incentive Compensation (IC) 1. Patient is an individual on therapy for a disease he/she is suffering. 2. NBRx is New Patient Start on a new drug. Sales reps feel they have more influence on NBRx in comparison to TRx, which they perceive as being more dependent on ongoing patient compliance. 3. NRx includes any new prescription: new-to-brand, new script, renewal of expired scripts. NRx remains a popular proxy for patient-oriented metrics. However, if it is used as Incentive Compensation (IC) metric, it may encourage the reps to influence HCPs to write shorter duration scripts, so they can get higher NRx volume. What the above means is that 1 patient can have multiple NBRx and each NBRx can have multiple NRx. NRx and TRx combinations are better metrics for IC. Example of Patient, NBRx and NRx: Patient A is suffering from NSCLC (type of lung cancer). > Physician puts this patient on Cisplatin (chemo therapy) for three months - First NBRx and also termed as NRx. >Now after three months of Cisplatin therapy, physician writes Cisplatin for two more months. This would be termed as another NRx >After Cisplatin, Physician switches the patient A to Opdivo (Immuno-oncology) for a month which would be termed as another NBRx as well as NRx Basically, there is 1 Patient A, 2 NBRx (Cisplatin & Opdivo) and 3 NRx (2 from Cisplatin and 1 Opdivo) (and 12 TRx, assuming Cisplatin as well as Opdivo are given every 15 days: 3 months + 2 months on Cisplatin and 1 month on Opdivo = 6 months * 2 TRx = 12 TRx) Source: My experience and IQVIA blog

10

The choices of modern customer engagement technologies have never been better. Regardless if you are eventually choosing between Veeva Systems Vault CRM or Salesforce Life Sciences Cloud. You are probably considering that, right now. However, what can be said of both solutions, is that they cater particularly well for the different commercial persona - after your product has made it to market. MSL, KAM, general rep persona and Marketing. What they don't cater for is, and arguable the most important person of all; the Market Access persona. What if your product never makes it to market? Therefore, make sure you, that make the right choices first.. Certara | BaseCase Interactive caters for the Market Access persona. Unlike conventional e-detailing and CLM solutions, Basecase provides unique functionality to communicate your Health Economics (HE) models to your payer customers. Here, conventional solutions won't suffice. https://lnkd.in/dGGJqqTn Communicating your HE value is a much more data/model driven and complex exercise, compared to communicating the your value claims for obtaining increased subscription with the prescribers - only after your product has been accepted into the market. All market access challenges are different, so make sure, that you have the right Health Economics models, and technology solutions to deliver compelling value communications for gaining market access. Solve the most important problem, first! Certara is here to support you with both Evidence, Value and Access consulting and Certara | BaseCase Interactive technology solutions. If you want to hear more, then please do reach out to: Greta Vainikauskaite (EMEA) greta.vainikauskaite@certara.com Daniel Goldstein (US & South America) daniel.goldstein@certara.com Or myself: morten.lindaa@certara.com #marketaccess #veevavaultCRM #salesforcelifesciencescloud #certara #basecase

37

Use of AI in drug discovery

2

🧬 The Future of Life Sciences on the Einstein 1 Platform 🧬 Discover how to future-proof your business in #Biotech, #Pharma, #ConsumerHealth, and #MedTech with our innovative Life Sciences Cloud.

7

It’s one of the most exciting ideas in medicine: prenatal gene therapy could correct gene mutations in fetuses, potentially preventing a lifetime of illness. However, ethical concerns arise. During the 2024 American Society for Gene and Cell Therapy meeting, UCSF anthropologist Julia Brown, Ph.D., highlighted the ethical considerations of prenatal gene therapy. The ethical concerns with prenatal gene therapy are wide-ranging and often overlap with concerns around gene therapy in general, ranging from logistical issues like cost to broader philosophical concerns around the impact such therapies could have on society more broadly. But prenatal gene therapy is unique in that there are two patients involved. Read more below! #GeneTherapy #Ethics #Healthcare #Innovation

8